Regenxbio (RGNX) Assets Average (2015 - 2026)

Regenxbio's Assets Average history runs 11 years deep, the most recent figure standing at $489.1 million for Q4 2025.

• In Q4 2025, Assets Average fell 0.7% year-over-year to $489.1 million; the TTM figure through Dec 2025 stood at $489.1 million (down 0.7% YoY), while the FY2025 annual figure was $459.5 million, down 11.63% from the prior year.
• Assets Average for Q4 2025 stood at $489.1 million, down from $553.1 million in the prior quarter.
• The five-year high for Assets Average was $1.1 billion in Q1 2022, with the low at $478.5 million in Q1 2025.
• The 5-year median for Assets Average is $686.6 million (2023), against an average of $716.3 million.
• The sharpest annual moves came in 2021 and 2023: Assets Average soared 87.8% in 2021, then slipped 29.66% in 2023.
• Regenxbio's Assets Average stood at $957.1 million in 2021, then decreased by 10.3% to $858.5 million in 2022, then retreated by 29.66% to $603.9 million in 2023, then slipped by 18.44% to $492.6 million in 2024, then retreated by 0.7% to $489.1 million in 2025.
• Business Quant data shows RGNX's Assets Average at $489.1 million in Q4 2025, $553.1 million in Q3 2025, and $536.0 million in Q2 2025.